CN102000236A - Method for preparing volatile oil inclusion compound and application thereof - Google Patents
Method for preparing volatile oil inclusion compound and application thereof Download PDFInfo
- Publication number
- CN102000236A CN102000236A CN201010566071XA CN201010566071A CN102000236A CN 102000236 A CN102000236 A CN 102000236A CN 201010566071X A CN201010566071X A CN 201010566071XA CN 201010566071 A CN201010566071 A CN 201010566071A CN 102000236 A CN102000236 A CN 102000236A
- Authority
- CN
- China
- Prior art keywords
- oil
- volatile oil
- beta
- clathrate
- schardinger dextrin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
Abstract
The invention provides a method for preparing a volatile oil inclusion compound and application thereof. The method for preparing the volatile oil inclusion compounds comprises the step of: including patchouli and volatile oil in perilla frutescens with beta-cyclodextrin through a homogeneous method. The inclusion compound prepared by the method can be used for preparing Huoxiang Zhengqishui so that the Huoxiang Zhengqishui can be free of alcohol, obtains improved stability, has no irritation and good mouth feeling, thereby enlarging the clinic and market application range of the Huoxiang Zhengqishui.
Description
Technical field
The invention belongs to field of traditional Chinese, relate to a kind of method and application thereof for preparing volatile oil clathrate compound, be specifically related to the preparation method of HUOXIANG ZHENGQI SHUI.
Background technology
Ageratum side comes from famous TCM work " prescription of peaceful benevolent dispensary ", is principal agent with the Herba Pogostemonis of the hot temperature of fragrance, its effect can be just gas or not.What is called is just gas not, is meant the spleen and stomach function disorder, and vomiting and diarrhoea takes place.Ageratum side is made up of Herba Pogostemonis, Pericarpium Arecae, the Radix Angelicae Dahuricae, Folium Perillae, Poria, Pinellia leaven, the Rhizoma Atractylodis Macrocephalae, Pericarpium Citri Reticulatae, Cortex Magnoliae Officinalis, Radix Glycyrrhizae Preparata.Has in the harmony in the exterior of separating the effect of regulating QI to expel dampness.Cure mainly affection of exogenous wind-cold.Clinical manifestation mainly contains full vexed, the epigastric pain of heating (low grade fever), aversion to cold, headache, chest and diaphragm, nausea and vomiting, borborygmus diarrhoea, tastelessness, white and greasy fur etc.It is slow because of the raw menstruation that causes that it can treat the women; Andrology is raw makes a bet and cholera, vomiting and diarrhoea, pyretic cold that summer is common; Even skin eczema also can be eliminated symptom in external ageratum side.
Ancients are made into powder more and take, so be called " huoxiang zhengqi powder ".Ageratum is dispersed in when taking and will just can takes with after frying in shallow oil with 3 in Rhizoma Zingiberis Recens, 1 piece in Fructus Jujubae.In order to solve the defective of taking inconvenience, doctor scholar has afterwards made pill with huoxiang zhengqi powder, and two kinds of honeyed pill, the watered pills are arranged, and is called HUOXIANG ZHENGQI WAN, has replaced huoxiang zhengqi powder.But the pill dose is big, and mouthfeel is also not so good.Along with the development of Chinese patent medicine preparation technology, made several formulations such as HUOXIANG ZHENGQI SHUI, HUOXIANG ZHENGQI YE, HUOXIANG ZHENGQI RUANJIAONANG in recent years again, different preparations respectively have superiority and shortcoming.
HUOXIANG ZHENGQI SHUI is recorded in one one of Chinese Pharmacopoeia version in 2010, compares with other ageratum square preparations, and HUOXIANG ZHENGQI SHUI has following advantage: the active constituent content height, curative effect height, medication dose are less relatively, play a role rapidly.But alcohol content is not answered steering vehicle or operation precision instrument, to Ying Shenyong such as ethanol allergy sufferers, children's, anemia of pregnant woman up to 40%～50% in the HUOXIANG ZHENGQI SHUI after taking.
Summary of the invention
Therefore, the objective of the invention is, a kind of method for preparing volatile oil clathrate compound is provided.
Another object of the present invention is that a kind of method for preparing HUOXIANG ZHENGQI SHUI is provided.
The objective of the invention is to be achieved through the following technical solutions.On the one hand, the invention provides a kind of method for preparing volatile oil clathrate compound, described method is carried out enclose by the homogenizing method to volatile oil for adopting beta-schardinger dextrin-, may further comprise the steps: 1) get beta-schardinger dextrin-, make the beta-schardinger dextrin-aqueous solution with water by 1: 1～10 w/v (mg/ml); 2) get volatile oil, make the volatile oil alcoholic solution with 95% ethanol by 1: 10～20 volume ratio (ml/ml), and the w/v of beta-schardinger dextrin-and volatile oil (mg/ml) is 10: 1; 3) with step 2) the volatile oil alcoholic solution of preparation drips in the beta-schardinger dextrin-aqueous solution of step 1) preparation, and homogenizing is handled after 30 seconds, in 30～50 ℃ of following enclose 10～50min, place 12～48h for 2～8 ℃, sucking filtration, ether washing, drying promptly gets the dried clathrate of white powder.
Preferably, described volatile oil is the mixture of patchouli oil and Folium perillae acutae oil; Preferably, described patchouli oil mixes by 2: 1 volume ratio with Folium perillae acutae oil.
Preferably, in the described step 1), the w/v of beta-schardinger dextrin-and water (mg/ml) is 1: 5.
Preferably, described step 2) in, volatile oil and 95% alcoholic acid volume ratio (ml/ml) they are 1: 20.
Preferably, the enclose temperature in the described step 3) is 50 ℃, and the enclose time is 50min.
The present invention also provides the volatile oil clathrate compound of method for preparing, and described volatile oil is the mixture of patchouli oil and Folium perillae acutae oil.Preferably, described patchouli oil mixes by 2: 1 volume ratio with Folium perillae acutae oil.
On the other hand, the invention provides a kind of method for preparing HUOXIANG ZHENGQI SHUI, described method comprises the step that adopts the method for preparing volatile oil clathrate compound.
The present invention also provides the HUOXIANG ZHENGQI SHUI of method for preparing, and patchouli oil that comprises in the described HUOXIANG ZHENGQI SHUI and Folium perillae acutae oil exist with the form of Benexate Hydrochloride.
In sum, the present invention is by a large amount of experiments, the preparation technology of optimization patchouli oil and Folium perillae acutae oil clathrate, prepared clathrate can be used for the exploitation that HUOXIANG ZHENGQI SHUI does not contain ethanol (ethanol) preparation, be about to patchouli oil, perilla oil carries out allocating in the preparation again behind the enclose with beta-schardinger dextrin-, can reduce or eliminate the alcohol content in the HUOXIANG ZHENGQI SHUI, improve the stability of HUOXIANG ZHENGQI SHUI, improve the mouthfeel of HUOXIANG ZHENGQI SHUI, reducing HUOXIANG ZHENGQI SHUI stimulates gastrointestinal, reduce the influence of the untoward reaction of HUOXIANG ZHENGQI SHUI and ethanol thus, enlarged the clinical of HUOXIANG ZHENGQI SHUI and market applicable surface the people.
In a preferred embodiment of the invention, the preparation technology of HUOXIANG ZHENGQI SHUI is as follows: (1) gets prescription composition patchouli oil, the Folium perillae acutae oil beta-cyclodextrin inclusion compound of HUOXIANG ZHENGQI SHUI, makes volatile oil clathrate compound.(2) all the other compositions of HUOXIANG ZHENGQI SHUI use the method preparation back according to Chinese Pharmacopoeia (version was an one in 2010) record to add volatile oil clathrate compound.Zhi Bei HUOXIANG ZHENGQI SHUI is soft thus, and stability improves, nonirritant, and mouthfeel is good.
The specific embodiment
Followingly the present invention is described with reference to specific embodiment.It will be appreciated by those skilled in the art that these embodiment only are used to illustrate the present invention, the scope that it does not limit the present invention in any way.
Below the volatile oil that uses among each embodiment, be to mix by patchouli oil and Folium perillae acutae oil volume ratio with 2: 1.
The extracting method of patchouli oil is as follows: with the Herba Pogostemonis pulverizing medicinal materials, take by weighing 200g, the 3000ml round-bottomed flask of packing into adds water 2000ml (10 times), connect volatile oil extractor, be heated to boiling, pick up counting, keep boiling 4h, leave standstill 1h, collect patchouli oil 1.0ml.
The extracting method of Folium perillae acutae oil is as follows: with the Folium Perillae pulverizing medicinal materials, take by weighing 200g, the 3000ml round-bottomed flask of packing into adds water 2000ml (10 times), connect volatile oil extractor, be heated to boiling, pick up counting, keep boiling 4h, leave standstill 1h, collect Folium perillae acutae oil 1.1ml.。
Beta-schardinger dextrin-is available from the sharp pharmaceutcal corporation, Ltd in Qufu City sky.
Below among each embodiment, the volatile oil volume of measuring in the clathrate by an appendix X of Chinese Pharmacopoeia version in 2010 D determination of volatile oil method (takes by weighing and amounts to the clathrate that contains 1ml volatile oil, put in the 250ml round-bottomed flask, add 100ml distilled water and zeolite, measure with volatile oil extractor, read the volatilization oil mass), press the relative density that appendix VII A1 pycnometric method is measured mixed volatilization oil, be calculated as follows clathrate yield and inclusion essential oil rate etc. respectively:
Clathrate yield (%)=dried clathrate weight * 100%/(beta-schardinger dextrin-weight+volatilization oil mass * density)
Actual oil content in inclusion rate (%)=clathrate * 100%/volatile oil input amount * blank response rate
Volatile oil yield (ml) * relative density in clathrate oil content (%)=clathrate * 100%/clathrate weight (g) * blank response rate
Volatile oil yield (ml) in clathrate volatile oil utilization rate (%)=clathrate * 100%/volatile oil addition (ml) * blank response rate
Wherein, the assay method of the blank response rate is as follows: precision is measured volatile oil 10ml, puts in the volatile oil extractor, adds distilled water 100ml, by last method distillating extracting oil and reading, calculates the blank response rate.Blank distillating extracting oil is 9.6ml (n=2), so the blank response rate is 96%.
Embodiment 1The screening of inclusion essential oil method
The clathrate process of volatile oil is generally saturated water solution method, polishing, supercritical ultrasonics technology and homogenizing method, considers the operability and the industrialization of technology, and present embodiment is only examined or check saturated water solution method, supercritical ultrasonics technology and homogenizing method.
The clathrate preparation method: by each experiment condition, it is an amount of that precision takes by weighing beta-schardinger dextrin-, places in the beaker, and the adding distilled water is an amount of, and heated and stirred makes dissolving, makes clear and bright solution, and constant temperature is to the enclose temperature.Drip volatile oil 1ml enclose under stirring, place about 48h in 2～8 ℃ of refrigerators writing time, sucking filtration, with the repeatedly washing (flush away is the volatile oil of enclose not) on a small quantity of 10～20ml ether, 40 ℃ of dry about 4h get the dried clathrate of white powder.
1) saturated water solution method
(5g of β-CD) adds water and makes 5% β-CD saturated aqueous solution, and with 5ml 95% ethanol dilution, the alcoholic solution that stirs down volatile oil is added drop-wise in the β-CD solution that is heated to 50 ℃ with 1ml volatile oil, and insulation continues to stir enclose 10min to take by weighing beta cyclodextrin.Enclose solution is put the refrigerator and cooled Tibetan and is spent the night, sucking filtration, and clathrate washs with a small amount of ether, puts (40 ℃) drying in the constant temperature oven, weighs, and measures volatile oil content in the clathrate, calculates the inclusion rate of volatile oil in the clathrate.
2) supercritical ultrasonics technology
Take by weighing beta cyclodextrin (5g of β-CD) adds water and makes 5% β-CD saturated aqueous solution, with 1ml volatile oil with 5ml 95% ethanol dilution, under ultrasonic state (250W, 33kHz) alcoholic solution that drips volatile oil is to being heated in β-CD solution of 50 ℃ insulation, lasting ultrasonic, enclose 10min.Enclose solution is put the refrigerator and cooled Tibetan and is spent the night, sucking filtration, and clathrate washs with a small amount of ether, puts (40 ℃) drying in the constant temperature oven, weighs, and measures volatile oil content in the clathrate, calculates the inclusion rate of volatile oil in the clathrate.
3) homogenizing method
Take by weighing the beta cyclodextrin (5g of β-CD), add water and make 5% β-CD saturated aqueous solution, with 1ml volatile oil 5ml 95% ethanol dilution, the alcoholic solution with volatile oil under stirring is added drop-wise in the β-CD solution that is heated to 50 ℃, insulation was handled (2 grades) about 30 seconds with homogenizer.Enclose solution is put the refrigerator and cooled Tibetan and is spent the night, sucking filtration, and clathrate washs with a small amount of ether, puts (40 ℃) drying in the constant temperature oven, weighs, and measures volatile oil content in the clathrate, calculates the inclusion rate of volatile oil in the clathrate.
The result is as shown in table 1.The inclusion rate that shows three kinds of processing methods is: homogenizing method＞supercritical ultrasonics technology＞saturated water solution method.
The inclusion rate of table 1 distinct methods enclose volatile oil
| Saturated water solution method | Supercritical ultrasonics technology | The homogenizing method |
| 81.9％ | 84.7％ | 86.2％ |
Embodiment 2The screening of inclusion essential oil process conditions and checking
1) investigation of different ethanol concentration dissolving inclusion essential oil effect
Take by weighing 3 parts of 5g β-CD respectively in triangular flask, add a certain amount of distilled water, heating for dissolving is made 5% β-CD saturated aqueous solution, and 1ml volatile oil is used 10ml Different concentrations of alcohol (95%, 80%, 65%) dissolving respectively, adopts the homogenizing method to carry out enclose.
The results are shown in Table 2, show that to adopt the enclose effect of 95% dissolve with ethanol volatile oil best.
The inclusion rate of table 2 different concentration ethanol dissolving volatile oil
| 95% ethanol | 80% ethanol | 65% ethanol |
| 85.7％ | 80.2％ | 74.3％ |
2) investigation of ethanol different amounts enclose volatile oil effect
Take by weighing 3 parts of 5g β-CD respectively in triangular flask, add a certain amount of distilled water, heating for dissolving is made 5% β-CD saturated aqueous solution, and 1ml volatile oil is used 95% ethanol (10,15, the 20ml) dissolving of different volumes respectively, adopts the homogenizing method to carry out enclose.
The results are shown in Table 3, show that the enclose result with 20ml dissolve with ethanol 1ml volatile oil slightly is better than other 2 groups, but the enclose result difference is not remarkable between three groups.
The inclusion rate of table 395% ethanol different amounts dissolving volatile oil
| 10ml 95% ethanol | 15ml 95% ethanol | 20ml 95% ethanol |
| 84.9％ | 84.2％ | 86.7％ |
3) enclose quadrature optimal process
Preliminary experiment is determined the ratio of beta-schardinger dextrin-and volatile oil ratio, enclose temperature, enclose time, beta-schardinger dextrin-and water for influencing the principal element of enclose.According to experiment condition each factor is determined 3 levels, adopt L9 (3
4) the orthogonal table experiment arrangement, be evaluation index with clathrate yield and inclusion rate.
Press L9 (3
4) requirement of orthogonal design scheme, take by weighing β-CD number respectively part in triangular flask, add a certain amount of distilled water, heating for dissolving is made β-CD saturated aqueous solution.With 1ml volatile oil 20ml95% dissolve with ethanol, press table 4 condition, stir in the β-CD solution that down alcoholic solution of volatile oil slowly is added drop-wise to 50 ℃.Dropwise, insulation, homogenizer was handled (2 grades) about 30 seconds.Put the refrigerator and cooled Tibetan and spend the night, sucking filtration is put (40 ℃) drying in the constant temperature oven.Clathrate washs with a small amount of ether, gets the white powder clathrate, weighs, and measures volatile oil content in the clathrate, calculates the inclusion rate of volatile oil in the clathrate.
Table 4 inclusion essential oil factor level table
Inclusion essential oil orthogonal test and The results of analysis of variance see Table 5, table 6.
Table 5 inclusion essential oil orthogonal test table
| Tested number | A | B | C | D | Inclusion essential oil rate (%) |
| 1 | 3∶1 | 10 | 30 | 1∶1 | 78.12 |
| 2 | 3∶1 | 30 | 40 | 1∶5 | 79.04 |
| 3 | 3∶1 | 50 | 50 | 1∶10 | 84.12 |
| 4 | 5∶1 | 10 | 40 | 1∶10 | 81.23 |
| 5 | 5∶1 | 30 | 50 | 1∶1 | 79.06 |
| 6 | 5∶1 | 50 | 30 | 1∶5 | 80.04 |
| 7 | 10∶1 | 10 | 50 | 1∶5 | 80.87 |
| 8 | 10∶1 | 30 | 30 | 1∶10 | 85.79 |
| 9 | 10∶1 | 50 | 40 | 1∶1 | 86.09 |
| Average 1 | 80.427 | 80.073 | 81.317 | 81.090 | |
| Average 2 | 80.110 | 81.297 | 82.120 | 79.983 | |
| Average 3 | 84.250 | 83.417 | 81.350 | 83.713 | |
| Extreme difference | 4.140 | 3.344 | 0.803 | 3.730 |
Table 6 analysis of variance table
| Source of variation | Sum of square of deviations | Degree of freedom | The F ratio |
| Beta-schardinger dextrin-: volatile oil | 31.858 | 2 | 1.763 |
| Time | 17.169 | 2 | 0.950 |
| Temperature | 1.239 | 2 | 0.069 |
| Beta-schardinger dextrin-: water | 22.019 | 2 | 1.218 |
Orthogonal experiment results is carried out intuitive analysis and variance analysis as can be known, and the concentration of the ratio of volatile oil and beta-schardinger dextrin-and enclose time, beta-schardinger dextrin-has the highly significant influence to experimental result, and the enclose temperature does not make significant difference, and influence degree is A＞D＞B＞C.Best clathrate process is A3B3C3D2, and promptly beta-schardinger dextrin-and volatile oil ratio are 10: 1, and the enclose temperature is 50 ℃, and the enclose time is 50min, and beta-schardinger dextrin-and water ratio are 1: 5.
4) inclusion essential oil technology is amplified and demonstration test
Get with 3 parts of a collection of volatile oil, every part of 5ml carries out enclose by above-mentioned best clathrate process.40 ℃ of dryings of clathrate are weighed.Result of the test sees Table 7, table 8.
The relative density measurement result (n=3) of table 7 volatile oil
| Sequence number | Bottle heavy (g) | Add (g) behind the water | After refueling (g) | Water heavy (g) | Oil heavy (g) | Relative density |
| 1 | 7.624 | 13.259 | 13.124 | 5.639 | 5.500 | 0.975 |
| 2 | 7.439 | 13.147 | 13.002 | 5.708 | 5.563 | 0.975 |
| 3 | 7.473 | 13.155 | 13.014 | 5.682 | 5.541 | 0.975 |
Table 8 inclusion essential oil demonstration test calculation of parameter result (n=3)
| Sequence number | Clathrate weight (g) | Clathrate yield (%) | Oil content (%) | Inclusion essential oil rate (%) |
| 1 | 53.2 | 95.2 | 9.46 | 85.7 |
| 2 | 52.8 | 94.7 | 9.45 | 85.4 |
| 3 | 52.9 | 94.6 | 9.44 | 85.6 |
| On average | 53.0 | 94.8 | 9.45 | 85.6 |
By the quadrature variance analysis, the ratio of volatile oil and β--cyclodextrin and enclose time are the key factors that influences inclusion essential oil.Demonstration test shows that the clathrate yield is 94.8%, and the inclusion essential oil rate is 85.6%, is higher than in the orthogonal table result under the experiment condition.
Therefore, clathrate process amplifies and demonstration test, and determine that final optimization pass process combination condition is: beta-schardinger dextrin-and volatile oil ratio are 10: 1, and the enclose temperature is 50 ℃, and the enclose time is 50min, and beta-schardinger dextrin-and water ratio are 1: 5.
Above result shows that also this process repeatability is better, steady quality, and clathrate recovery rate and oily inclusion rate are all higher.Volatile oil has been covered the abnormal smells from the patient of volatile oil effectively behind beta-cyclodextrin inclusion compound, keep the volatile oil physiologically active, thereby will improve the quality of formulation products.
Embodiment 4The preparation of HUOXIANG ZHENGQI SHUI
Prepare all the other prescription compositions of HUOXIANG ZHENGQI SHUI by the preparation method under HUOXIANG ZHENGQI SHUI item of Chinese Pharmacopoeia version in 2005: Rhizoma Atractylodis, Pericarpium Citri Reticulatae, Cortex Magnoliae Officinalis, the Radix Angelicae Dahuricae are made solvent with 60% ethanol respectively, flood and carry out percolation after 24 hours, first three is planted each and collects the liquid 400ml that just filters, the first liquid 500ml that filters of a kind of collection in back, standby, continue percolation, collect the continuous liquid of filtering, incorporate in the liquid of just filtering after concentrating.After Poria adds water boil, 80 ℃ of warm macerating secondaries, 3 hours for the first time, 2 hours for the second time, extracting juice; The Rhizoma Pinelliae cold water soak was changed water once in per 8 hours, and bubble is to the saturating heart, and other adds Rhizoma Zingiberis 13.5g, decocts with water secondary, and 3 hours for the first time, 2 hours for the second time; Pericarpium Arecae decocts with water 3 hours, and Radix Glycyrrhizae extractum is smashed the back decocting in water and melted; Merge said extracted liquid, filter, filtrate is concentrated in right amount.Patchouli oil, Folium perillae acutae oil clathrate water by best clathrate process preparation among the embodiment 3 dissolved in right amount.Merge above solution, mixing adds water and makes full dose become 2050ml in right amount, fill, promptly.
Claims (8)
1. a method for preparing volatile oil clathrate compound is characterized in that, described method is carried out enclose by the homogenizing method to volatile oil for adopting beta-schardinger dextrin-, may further comprise the steps:
1) gets beta-schardinger dextrin-, make the beta-schardinger dextrin-aqueous solution by 1: 1～10 w/v (mg/ml) with water;
2) get volatile oil, make the volatile oil alcoholic solution with 95% ethanol by 1: 10～20 volume ratio (ml/ml), and the w/v of beta-schardinger dextrin-and volatile oil (mg/ml) is 10: 1;
3) with step 2) the volatile oil alcoholic solution of preparation drips in the beta-schardinger dextrin-aqueous solution of step 1) preparation, and homogenizing is handled after 30 seconds, in 30～50 ℃ of following enclose 10～50min, place 12～48h for 2～8 ℃, sucking filtration, ether washing, drying promptly gets the dried clathrate of white powder.
2. method according to claim 1 is characterized in that, described volatile oil is the mixture of patchouli oil and Folium perillae acutae oil; Preferably, described patchouli oil mixes by 2: 1 volume ratio with Folium perillae acutae oil.
3. method according to claim 1 and 2 is characterized in that, in the described step 1), the w/v of beta-schardinger dextrin-and water (mg/ml) is 1: 5.
4. according to each described method in the claim 1 to 3, it is characterized in that described step 2) in, volatile oil and 95% alcoholic acid volume ratio (ml/ml) they are 1: 20.
5. according to each described method in the claim 1 to 4, it is characterized in that the enclose temperature in the described step 3) is 50 ℃, the enclose time is 50min.
6. the volatile oil clathrate compound of each described method preparation in the claim 1 to 5, described volatile oil is the mixture of patchouli oil and Folium perillae acutae oil; Preferably, described patchouli oil mixes by 2: 1 volume ratio with Folium perillae acutae oil.
7. a method for preparing HUOXIANG ZHENGQI SHUI is characterized in that, described method comprises the step that adopts each described method in the claim 1 to 5 to prepare volatile oil clathrate compound.
8. the HUOXIANG ZHENGQI SHUI of the described method preparation of claim 7 is characterized in that patchouli oil that comprises in the described HUOXIANG ZHENGQI SHUI and Folium perillae acutae oil exist with the form of Benexate Hydrochloride.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201010566071XA CN102000236B (en) | 2010-11-23 | 2010-11-23 | Method for preparing volatile oil inclusion compound and application thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201010566071XA CN102000236B (en) | 2010-11-23 | 2010-11-23 | Method for preparing volatile oil inclusion compound and application thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102000236A true CN102000236A (en) | 2011-04-06 |
| CN102000236B CN102000236B (en) | 2012-05-23 |
Family
ID=43808105
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201010566071XA Active CN102000236B (en) | 2010-11-23 | 2010-11-23 | Method for preparing volatile oil inclusion compound and application thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102000236B (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103109879A (en) * | 2013-02-27 | 2013-05-22 | 绍兴文理学院元培学院 | Preparation method of torreya grandis aril essential oil clathrate compound |
| CN106822919A (en) * | 2017-03-14 | 2017-06-13 | 胡江宇 | A kind of peppermint oil sustained release inclusion compound and preparation method thereof |
| CN107362318A (en) * | 2017-08-23 | 2017-11-21 | 华子昂 | The ionization Chinese medicine composition of Xie Yu that calms the nerves a kind of and its application |
| CN107582770A (en) * | 2017-09-20 | 2018-01-16 | 华子昂 | A kind of strongly fragrant ionization Chinese medicine composition of inducing resuscitation solution and its application |
| CN109432379A (en) * | 2018-12-27 | 2019-03-08 | 广东化州中药厂制药有限公司 | The preparation method of ageratum mixture |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1593635A (en) * | 2004-06-25 | 2005-03-16 | 张晴龙 | Orally disintegrating tablet of 'Huoxiang Zhengqi' and its preparation process |
| CN1698851A (en) * | 2005-05-23 | 2005-11-23 | 湘潭大学 | Stomach nourishing dispersible tablet with aucklandia root and amomum fruit and its preparation method |
| CN1939525A (en) * | 2006-09-27 | 2007-04-04 | 广州市香雪制药股份有限公司 | Production of antiviral oral liquid |
| CN101020034A (en) * | 2007-04-02 | 2007-08-22 | 李宏良 | Prepn process of medicine for treating cerebral apoplexy and its sequela |
| CN101732657A (en) * | 2008-11-19 | 2010-06-16 | 北京卓越同创药物研究院 | Medicine composition |
| CN101810864A (en) * | 2010-04-22 | 2010-08-25 | 北京卓越同创药物研究院 | Preparation method of volatile oil beta-cyclodextrin inclusion compound |
| CN101822713A (en) * | 2010-05-06 | 2010-09-08 | 茂名学院 | Method for preparing pogostemon cablin volatile oil beta-cyclodextrin clathrate compound by ultrasonic method |
-
2010
- 2010-11-23 CN CN201010566071XA patent/CN102000236B/en active Active
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1593635A (en) * | 2004-06-25 | 2005-03-16 | 张晴龙 | Orally disintegrating tablet of 'Huoxiang Zhengqi' and its preparation process |
| CN1698851A (en) * | 2005-05-23 | 2005-11-23 | 湘潭大学 | Stomach nourishing dispersible tablet with aucklandia root and amomum fruit and its preparation method |
| CN1939525A (en) * | 2006-09-27 | 2007-04-04 | 广州市香雪制药股份有限公司 | Production of antiviral oral liquid |
| CN101020034A (en) * | 2007-04-02 | 2007-08-22 | 李宏良 | Prepn process of medicine for treating cerebral apoplexy and its sequela |
| CN101732657A (en) * | 2008-11-19 | 2010-06-16 | 北京卓越同创药物研究院 | Medicine composition |
| CN101810864A (en) * | 2010-04-22 | 2010-08-25 | 北京卓越同创药物研究院 | Preparation method of volatile oil beta-cyclodextrin inclusion compound |
| CN101822713A (en) * | 2010-05-06 | 2010-09-08 | 茂名学院 | Method for preparing pogostemon cablin volatile oil beta-cyclodextrin clathrate compound by ultrasonic method |
Non-Patent Citations (7)
| Title |
|---|
| 《中国中医药信息杂志》 20081015 王瑞海等 广藿香挥发油包合工艺研究 , 第10期 2 * |
| 《中国药房》 20060215 李春花等 正交试验优化鼻渊灵颗粒中挥发油的包合工艺 , 第03期 2 * |
| 《中成药》 20090420 李钟等 广藿香和佩兰挥发油提取和包合工艺的研究 , 第04期 2 * |
| 《四川省卫生管理干部学院学报》 20090315 余凌英等 健脾止泻颗粒挥发油提取与包合工艺研究 , 第01期 2 * |
| 《江西中医学院学报》 20000613 姜洪芳等 beta-环糊精包合物在中药药剂中的研究进展及应用状况分析 , 第02期 2 * |
| 《湖北中医杂志》 20010410 李建春等 广藿香挥发油beta-环糊精包合工艺的研究 , 第04期 2 * |
| 《长春中医学院学报》 20030925 李宜平等 藿香挥发油beta-环糊精包合物制备工艺研究 , 第03期 2 * |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103109879A (en) * | 2013-02-27 | 2013-05-22 | 绍兴文理学院元培学院 | Preparation method of torreya grandis aril essential oil clathrate compound |
| CN103109879B (en) * | 2013-02-27 | 2014-11-26 | 绍兴文理学院元培学院 | Preparation method of torreya grandis aril essential oil clathrate compound |
| CN106822919A (en) * | 2017-03-14 | 2017-06-13 | 胡江宇 | A kind of peppermint oil sustained release inclusion compound and preparation method thereof |
| CN107362318A (en) * | 2017-08-23 | 2017-11-21 | 华子昂 | The ionization Chinese medicine composition of Xie Yu that calms the nerves a kind of and its application |
| CN107582770A (en) * | 2017-09-20 | 2018-01-16 | 华子昂 | A kind of strongly fragrant ionization Chinese medicine composition of inducing resuscitation solution and its application |
| CN109432379A (en) * | 2018-12-27 | 2019-03-08 | 广东化州中药厂制药有限公司 | The preparation method of ageratum mixture |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102000236B (en) | 2012-05-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102000236B (en) | Method for preparing volatile oil inclusion compound and application thereof | |
| CN101513519B (en) | Chinese medicinal composition for invigorating Qi and nourishing blood, preparation method and quality control method thereof | |
| CN100418512C (en) | 'Shengmai' infusion and its preparation process | |
| CN103800438B (en) | Ligusticum wallichii tea modulator and preparation method thereof | |
| CN102614281B (en) | Chinese medicinal composition for improving anoxia endurance and preparation method and application thereof | |
| CN104042824A (en) | Preparation and detecting methods of traditional Chinese medicine composition for treating wind-cold-wetness evil | |
| CN101129773A (en) | Granular formulation, tablet or capsule of black-bone chicken and white phoenix and method of preparing the same | |
| CN102357226B (en) | Application of Chinese herbal medicine turmeric extraction in preparation of drug with lipase activity inhibition effect | |
| CN102145089B (en) | Traditional Chinese medicine for treating heart failure | |
| CN103735712B (en) | Preparation method of Chinese medicinal composition and Chinese medicinal composition prepared by using preparation method | |
| CN101972465A (en) | Medicinal preparation for treating primary dysmenorrhea and preparation method thereof | |
| CN1895396B (en) | Chinese-medicinal preparation with Yin-nourishing, intestin-moistening and bowls-relaxing functions, and preparation method thereof | |
| CN101850100A (en) | Preparation method of puerperal blood stasis dissipating tablets | |
| CN102908441B (en) | Pain relieving micro-emulsion pharmaceutical composition gel ointment and preparation method thereof | |
| CN102028828B (en) | Medical composite for treating benign prostatic hyperplasia and urodialysis and detection method of medical composite | |
| CN102451442B (en) | Extraction process of anti-depression Chinese medicament | |
| CN103611074A (en) | Preparation process of breast health soft capsule by directly filling part of uniformly mixed powder into capsule | |
| CN103316074A (en) | Medicine composite of halenia corni extract, astragalus extract and liquorice extract as well as preparation and application of medicine composite | |
| CN100536871C (en) | Making method for medicinal composition and its preparation and quality controlling method | |
| CN102861159A (en) | Medicine composition for treating dysmenorrheal as well as preparation method and application thereof | |
| CN100348170C (en) | Yitongshu drop pill for treating pain and its preparation method | |
| CN103202873B (en) | Medicine composition used for enhancing human immunity | |
| CN1315463C (en) | Guanxinning drip pill for treating heart disease and its preparation method | |
| CN101371877B (en) | Qi tian dropping pill extract and Qi tian dropping pill as well as method for producing the same | |
| CN104042801A (en) | Preparation process of rhizoma alismatis lipid-lowering condensed pills |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant |